Enjoy complimentary customisation on priority with our Enterprise License!
The IVD market share in the US is expected to increase to USD 7.39 billion from 2020 to 2025, at a CAGR of 6.41%. This report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches.
This IVD market in the US research report extensively covers market segmentation in the US by technology (immunochemistry, molecular diagnostics, tissue diagnostics, hematology, and others) and component (consumables, instruments, and services).
The IVD market in the US report also offers information on several market vendors, including Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Sysmex Corp., and Thermo Fisher Scientific Inc. among others.
Download the Free Report Sample to Unlock the IVD Market Size in the US for the Forecast Period and Other Important Statistics
The increasing geriatric population, chronic, and infectious diseases is notably driving the IVD market growth in the US, although factors such as stringent regulatory bodies guiding IVD manufacturers may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the IVD industry in the US. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key IVD Market Driver in the US
The increasing geriatric population, chronic, and infectious diseases is one of the key drivers supporting the IVD market growth in the US. Viruses such as hepatitis B virus (HBV), hepatitis C virus (HCV), and others cause infectious diseases which require the need for IVD tests. The rising incidence rates of diseases such as diabetes and cancer are increasing the need to diagnose diseases at an early stage to ensure regular monitoring of patients to identify, treat, control, and limit the prevalence of diseases. Molecular diagnostic techniques like enzyme-linked immunoassay (ELISA) help in the early detection of infections through antigen and antibody interactions to mitigate diseases. Thus, changing demographics in the US, primarily including the aging population and incidence rates of diseases, will contribute to the growth of the IVD market during the forecast period.
Key IVD Market Trend in the US
Technological advances in IVD is another factor supporting the IVD market growth in the US. Advanced cutting-edge technologies like POCT, next-generation sequencing, near-patient testing, and others have revolutionized the IVD sector by providing an accurate and precise diagnosis at rapid rates. Furthermore, vendors focus on providing customized solutions through advancements in genomic technologies, contributing to the growth of personalized treatment care. Diagnostic companies collaborate with pharmaceutical companies to develop and provide targeted therapy solutions. For instance, bioMerieux provides personalized care diagnostic solutions. Thus, the increasing focus on personalized medicines will lead to the IVD market growth during the forecast period
Key IVD Market Challenge in the US
The stringent regulatory bodies guiding IVD manufacturers is hindering the IVD market growth in the US. IVD are tests conducted to examine blood, tissue, or fluid samples to monitor health conditions and to treat or prevent diseases. The design of devices, malfunctioning, and technical errors are some of the issues associated with the usage of these devices. Such issues can lead to misdiagnosis and improper patient management and treatment of several blood conditions and diseases. Hence, stringent government regulations are imposed on these devices. Also, during the submission for pre-market approval, the company must pay a minimum of USD 62,000 to the FDA, and the approval procedure is time-consuming. Even after the submission, there might be chances for devices to get approved or disapproved. Sometimes, the products may be recalled after approval due to malfunctioning issues. Hence fulfilling stringent government guidelines pose a threat to the growth of the IVD market in the US.
This IVD market in the US analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
Technavio categorizes the IVD market in the US as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the IVD market in the US during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the IVD market in the US encompasses successful business strategies deployed by the key vendors. The IVD market in the US is fragmented and the vendors are deploying growth strategies such as quality and price to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The IVD market in the US forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the IVD market in the US, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chains is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
The value chain of the healthcare equipment market includes the following core components:
The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.
To gain further insights on the market contribution of various segments Request for a FREE sample
The IVD market share growth in the US by the immunochemistry segment will be significant during the forecast period. Immunochemistry is a branch of chemistry, which involves the study of molecular mechanisms and functions of the immune system through interactions between antigens and corresponding antibodies. This technique primarily focuses on identifying and documenting high-resolution cellular components within cells and tissue constituents such as proteins and lipopolysaccharides in clinical diagnostics and medical research laboratories. It is more effective when compared with the effectiveness of traditional enzyme staining techniques as it involves specific antigen-antibody reactions. Such factors will drive the segment's growth during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the IVD market size in the US and actionable market insights on post COVID-19 impact on each segment.
China In-vitro Diagnostics (IVD) market - The market share will grow steadily over the next four years and post a CAGR of more than 14% by 2021.
Europe IVD market - The market share is expected to grow at a CAGR of around 5% during the forecast period.
|
IVD Market Scope in the US |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2020 |
|
Forecast period |
2021-2025 |
|
Growth momentum & CAGR |
Decelerate at a CAGR of 6.41% |
|
Market growth 2021-2025 |
$ 7.39 billion |
|
Market structure |
Fragmented |
|
YoY growth (%) |
8.97 |
|
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
|
Key companies profiled |
Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Sysmex Corp., and Thermo Fisher Scientific Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
***1. Executive Summary
**1.1 Market Overview
*Exhibit 01: Key Finding 1
*Exhibit 02: Key Finding 2
*Exhibit 03: Key Finding 6
*Exhibit 04: Key Finding 7
***2. Market Landscape
**2.1 Market ecosystem
*2.1.1 Parent Market
*Exhibit 05 Parent market
*Exhibit 06: Market characteristics
**2.2 Value Chain Analysis
*Exhibit 07: Value Chain Analysis: Healthcare Equipment
*2.2.1 Research and development
*2.2.2 Inputs
*2.2.3 Operations
*2.2.4 Distribution
*2.2.5 Marketing and sales
*2.2.6 Post-sales and services
*2.2.7 Industry innovations
***3. Market Sizing
**3.1 Market definition
*Exhibit 08: Offerings of vendors included in the market definition
**3.2 Market segment analysis
*Exhibit 09: Market segments
**3.3 Market size 2021
**3.4 Market outlook: Forecast for 2021 - 2026
*3.4.1Estimating growth rates for emerging and high-growth markets
*3.4.2Estimating growth rates for mature markets
*Exhibit 10: Global - Market size and forecast 2020 - 2025 ($ billion)
*Exhibit 11: Global market: Year-over-year growth 2020 - 2025 (%)
***4. Five Forces Analysis
**4.1 Five Forces Summary
*Exhibit 12: Five forces analysis 2020 - 2025
**4.2 Bargaining power of buyers
*Exhibit 13: Bargaining power of the buyer
**4.3 Bargaining power of suppliers
*Exhibit 14: Bargaining power of the supplier
**4.4 Threat of new entrants
*Exhibit 15: Threat of new entrants
**4.5 Threat of substitutes
*Exhibit 16: Threat of substitutes
**4.6 Threat of rivalry
*Exhibit 17: Threat of rivalry
**4.7 Market condition
*Exhibit 18: Market condition - Five forces 2020
***5. Market Segmentation by Technology
**5.1 Market segments
*Exhibit 19: Technology- Market share 2020 - 2025 (%)
**5.2 Comparison by Technology
*Exhibit 20: Comparison by Technology
**5.3 Immunochemistry - Market size and forecast 2020-2025
*Exhibit 21: Immunochemistry - Market size and forecast 2020-2025 ($ billion)
*Exhibit 22: Immunochemistry - Year-over-year growth 2020-2025 (%)
**5.4 Molecular diagnostics - Market size and forecast 2020-2025
*Exhibit 23: Molecular diagnostics - Market size and forecast 2020-2025 ($ billion)
*Exhibit 24: Molecular diagnostics - Year-over-year growth 2020-2025 (%)
**5.5 Tissue diagnostics - Market size and forecast 2020-2025
*Exhibit 25: Tissue diagnostics - Market size and forecast 2020-2025 ($ billion)
*Exhibit 26: Tissue diagnostics - Year-over-year growth 2020-2025 (%)
**5.6 Hematology - Market size and forecast 2020-2025
*Exhibit 27: Hematology - Market size and forecast 2020-2025 ($ billion)
*Exhibit 28: Hematology - Year-over-year growth 2020-2025 (%)
**5.7 Others - Market size and forecast 2020-2025
*Exhibit 29: Others - Market size and forecast 2020-2025 ($ billion)
*Exhibit 30: Others - Year-over-year growth 2020-2025 (%)
**5.8 Market opportunity by Technology
*Exhibit 31: Market opportunity by Technology
***6 Market Segmentation by Component
**6.1 Market segments
*Exhibit 32: Component- Market share 2021-2026 (%)
**6.2 Comparison by Component
*Exhibit 33: Comparison by Component
**6.3 Consumables - Market size and forecast 2020-2025
*Exhibit 34: Consumables - Market size and forecast 2020-2025 ($ billion)
*Exhibit 35: Consumables - Year-over-year growth 2020-2025 (%)
**6.4 Instruments - Market size and forecast 2020-2025
*Exhibit 36: Instruments - Market size and forecast 2020-2025 ($ billion)
*Exhibit 37: Instruments - Year-over-year growth 2020-2025 (%)
**6.5 Services - Market size and forecast 2020-2025
*Exhibit 38: Services - Market size and forecast 2020-2025 ($ billion)
*Exhibit 39: Services - Year-over-year growth 2020-2025 (%)
**6.6 Market opportunity by Component
*Exhibit 40: Market opportunity by Component
***7. Customer landscape
*Technavio’s customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria
**7.1 Overview
*Exhibit 41: Customer landscape
***8. Drivers, Challenges, and Trends
**8.1 Market drivers
*8.1.1 Increasing geriatric population, chronic, and infectious diseases
*8.1.2 High demand for personalized medicine
*8.1.3 Industry developments
**8.2 Market challenges
*1.1.1 Stringent regulatory bodies guiding IVD manufacturers
*1.1.2 Lack of skilled professionals
*1.1.3 Inadequate reimbursements
*1.1.4 Reduction in profits of manufacturers due to US medical device tax policies
*Exhibit 42: Impact of drivers and challenges
**8.3 Market trends
*8.3.1 Technological advances in IVD
*8.3.2 Adoption of advanced treatment solutions
*8.3.3 Innovations in digital IVD sector
*8.3.4 Growing adoption of automated diagnostic devices in healthcare industry
***9. Vendor Landscape
**9.1 Overview
*Exhibit 43: Vendor landscape
**9.2 Landscape disruption
*Exhibit 44: Landscape disruption
*Exhibit 45: Industry Risk
**9.3 Competitive Landscape
***10. Vendor Analysis
**10.1 Vendors covered
*Exhibit 46: Vendors covered
**10.2 Market positioning of vendors
*Exhibit 47: ?Market positioning of vendors?
**10.3 Abbott Laboratories
*Exhibit 48: Abbott Laboratories - Overview
*Exhibit 49: Abbott Laboratories - Business segments
*Exhibit 50: Abbott Laboratories - Key offerings
*Exhibit 51: Abbott Laboratories - Segment focus
**10.4 Becton Dickinson and Co.
*Exhibit 52: Becton Dickinson and Co. - Overview
*Exhibit 53: Becton Dickinson and Co. - Business segments
*Exhibit 54: Becton Dickinson and Co. - Key offerings
*Exhibit 55: Becton Dickinson and Co. - Segment focus
**10.5 Bio Rad Laboratories Inc.
*Exhibit 56: Bio Rad Laboratories Inc. - Overview
*Exhibit 57: Bio Rad Laboratories Inc. - Business segments
*Exhibit 58: Bio Rad Laboratories Inc. - Key offerings
*Exhibit 59: Bio Rad Laboratories Inc. - Segment focus
**10.6 bioMerieux SA
*Exhibit 60: bioMerieux SA - Overview
*Exhibit 61: bioMerieux SA - Product and service
*Exhibit 62: bioMerieux SA - Key offerings
**10.7 Danaher Corp.
*Exhibit 63: Danaher Corp. - Overview
*Exhibit 64: Danaher Corp. - Business segments
*Exhibit 65: Danaher Corp. - Key news
*Exhibit 66: Danaher Corp. - Key offerings
*Exhibit 67: Danaher Corp. - Segment focus
**10.8 DiaSorin SpA
*Exhibit 68: DiaSorin SpA - Overview
*Exhibit 69: DiaSorin SpA - Business segments
*Exhibit 70: DiaSorin SpA - Key offerings
*Exhibit 71: DiaSorin SpA - Segment focus
*10.9 F. Hoffmann-La Roche Ltd.
*Exhibit 72: F. Hoffmann-La Roche Ltd. - Overview
*Exhibit 73: F. Hoffmann-La Roche Ltd. - Business segments
*Exhibit 74: F. Hoffmann-La Roche Ltd. - Key offerings
*Exhibit 75: F. Hoffmann-La Roche Ltd. - Segment focus
**10.10 Siemens Healthineers AG
*Exhibit 76: Siemens Healthineers AG - Overview
*Exhibit 77: Siemens Healthineers AG - Business segments
*Exhibit 78: Siemens Healthineers AG - Key offerings
*Exhibit 79: Siemens Healthineers AG - Segment focus
**10.11 Sysmex Corp
*Exhibit 80: Sysmex Corp. - Overview
*Exhibit 81: Sysmex Corp. - Business segments
*Exhibit 82: Sysmex Corp. - Key news
*Exhibit 83: Sysmex Corp. - Key offerings
*Exhibit 84: Sysmex Corp. - Segment focus
**10.12 Thermo Fisher Scientific Inc.
*Exhibit 85: Thermo Fisher Scientific Inc. - Overview
*Exhibit 86: Thermo Fisher Scientific Inc. - Business segments
*Exhibit 87: Thermo Fisher Scientific Inc. - Key news
*Exhibit 88: Thermo Fisher Scientific Inc. - Key offerings
*Exhibit 89: Thermo Fisher Scientific Inc. - Segment focus
***11. Appendix
**11.1 Scope of the report
*11.1.1 ????Market definition
*11.1.2 ????Objectives
*11.1.3 ????Notes and caveats
**11.2 Currency conversion rates for US$
*Exhibit 90: ?Currency conversion rates for US$?
**11.3 Research Methodology
*Exhibit 91: ?Research Methodology
*Exhibit 92: ??Validation techniques employed for market sizing?
*Exhibit 93: ??Information sources
**11.4 List of abbreviations
*Exhibit 94: List of abbreviations
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
